CD5 is a 67 kDa type I glycoprotein which belongs to the Scavenger Receptor
Cysteine-Rich (SRCR)family of receptors. This family includes either cell-
surface (e.g. CD6) or secreted (e.g Sp alpha) proteins implicated in the de
velopment of the immune system and the regulation of immune responses. In t
his study, we purified and characterised a circulating natural soluble CD5
form (nsCD5) which is indistinguishable (in apparent molecular mass, glycos
ylation pattern, and antibody reactivity) from a recombinant soluble CD5 fo
rm (rsCD5) composed of the three extracellular SCRC domains. The nsCD5 is a
N-glycosylated 52 kDa molecule present in normal human serum and in supern
atants of in vitro phorbol ester- and CD3-stimulated peripheral blood monon
uclear cells. The nsCD5 concentration in sera from healthy donors is relati
vely low (median 1.75 ng/ml, n=166) and is similar to that found in sera fr
om patients suffering of various autoimmune (systemic lupus erythematosus,
primary Sjogren syndrome, rheumatoid arthritis) and non-autoimmune (chronic
renal failure, B-cell chronic lymphocytic leukemia) disorders. In vitro ex
periments indicate that nsCD5 is released by proteolytic cleavage of the me
mbrane form. These results represent the first evidence of proteolytic rele
ase of a transmembrane SRCR family member following cell activation.